Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.ttkhealthcare.com | |
Market Cap | 1,200.94 Cr. | |
Enterprise Value(EV) | 952.26 Cr. | 2021-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 29.24 | Trailing Twelve Months Ending 2021-12 |
Price-Earning Ratio (PE) | 29.07 | Trailing Twelve Months Ending 2021-12 |
Industry PE | 29.26 | Trailing Twelve Months Ending 2021-12 |
Book Value / Share | 223.24 | Trailing Twelve Months Ending 2021-12 |
Price to Book Value | 3.81 | Calculated using Price: 849.90 |
Dividend Yield | 0.71 | Period Ending 2021-03 |
No. of Shares Subscribed | 1.41 Cr. | 14,130,333 Shares |
FaceValue | 10 | |
Company Profile | ||
T T K Healthcare Ltd was incorporated in 1958 and went public in the same year. The company's brand wagon consists of products that are sought after by a wide range of customers. The Woodward's Gripe Water brand is the market leader in the baby care category. The Eva range of personal care products (Talc, Deodorant, Skincare) bring together the gentle touch of nature, backed by TTK's extensive research. TTK Healthcare has an All India sales and distribution network for marketing not only their own products, but also the KIWI Brand (Shoecare), Brylcreem (Haircare) and Kohinoor and Durex brands (Contraceptives). The company also specializes in sales and distribution in India as a joint venture partner. It has a successful tie up with Sara Lee Household and Bodycare Pvt. Ltd. and TTK-LIG Ltd. The company's distribution network comprises of 2800 redistribution stockists who cover both the urban and rural consumers. TTK Healthcare has three Strategic Business Units
TTK the three letters that stand for quality consumer products at affordable prices. A reputation built across eight decades. An organization that started out as an indenting agency and grew to what it is today with path-breaking marketing ideas. Those core values that created TTK into a force to be reckoned with continue to define the framework of the TTK Group even today. Product range of the company includes: Personal care- Eva range of women’s personal care products Pharmaceuticals Baby Care:
Animal Care
Heart Valve - India's first indigenous heart valve prosthesis - the tilting-disc TTK Chitra Heart Valve. Food - TTK Ready-to-fry Snack Pellets are available in a variety of flavors, shapes, colours and designs Maps- The Publications Division of TTK Healthcare is the largest producer of maps and map-based publications in the private sector. Achievements/ recognition:
|
1 Day |
|
+6.85% |
1 Week |
|
+13.02% |
1 Month |
|
+10.07% |
3 Month |
|
+18.33% |
6 Month |
|
+27.95% |
1 Year |
|
+44.30% |
2 Year |
|
+98.45% |
5 Year |
|
+9.02% |
10 Year |
|
+147.79% |
9 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
Return on Equity (%) | 16.07 | 12.64 | 14.94 | 18.46 | 13.16 | 9.52 | 10.25 | 5.01 | 17.37 | |
Return on Capital Employed (%) | 22.23 | 18.12 | 20.71 | 23.85 | 18.63 | 15.42 | 15.46 | 8.28 | 13.53 | |
Return on Assets (%) | 7.07 | 5.51 | 6.27 | 7.85 | 6.38 | 5.28 | 5.99 | 2.94 | 10.15 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2021-09* Rs. Cr. |
Shh. Funds | 98 | 107 | 118 | 136 | 157 | 233 | 251 | 249 | 295 | 308 | |
Non Curr. Liab. | 11 | 27 | 28 | 16 | 8 | 2 | 2 | 7 | 4 | 7 | |
Curr. Liab. | 100 | 106 | 129 | 150 | 120 | 168 | 157 | 172 | 189 | 206 | |
Minority Int. | |||||||||||
Equity & Liab. | 209 | 240 | 275 | 303 | 285 | 403 | 411 | 427 | 488 | 521 | |
Non Curr. Assets | 55 | 77 | 109 | 119 | 118 | 147 | 139 | 129 | 113 | 111 | |
Curr. Assets | 154 | 163 | 166 | 184 | 167 | 256 | 272 | 298 | 375 | 410 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 209 | 240 | 275 | 303 | 285 | 403 | 411 | 427 | 488 | 521 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2021-12 Rs. Cr. TTM |
Net Sales | 382 | 416 | 483 | 519 | 528 | 578 | 628 | 646 | 637 | 771 | |
Other Income | 7 | 6 | 7 | 6 | 6 | 8 | 8 | 9 | 10 | 15 | |
Total Income | 389 | 422 | 489 | 524 | 534 | 585 | 636 | 655 | 647 | 785 | |
Total Expenditure | -362 | -396 | -453 | -478 | -489 | -535 | -578 | -617 | -602 | -715 | |
PBIDT | 27 | 26 | 36 | 46 | 44 | 50 | 57 | 37 | 45 | 71 | |
Interest | -3 | -3 | -4 | -3 | -3 | -5 | -3 | -3 | -2 | -3 | |
Depreciation | -3 | -3 | -6 | -7 | -12 | -15 | -15 | -14 | -14 | -13 | |
Taxation | -7 | -7 | -10 | -13 | -10 | -12 | -15 | -7 | 9 | -16 | |
Exceptional Items | 8 | 2 | |||||||||
PAT | 14 | 12 | 16 | 23 | 19 | 18 | 24 | 12 | 46 | 41 | |
Adjusted EPS | 18 | 16 | 21 | 29 | 24 | 13 | 17 | 9 | 33 | 29 |
Particulars | 10 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
Cash Fr. Operatn. | 6 | 24 | 13 | 39 | 37 | 18 | 25 | 17 | 20 | 96 | |
Cash Fr. Inv. | -4 | -1 | -15 | -49 | -27 | 5 | -23 | 10 | -13 | -77 | |
Cash Fr. Finan. | -1 | -2 | 2 | 3 | -11 | -23 | -7 | -31 | -10 | -17 | |
Net Change | 1 | 22 | 0 | -7 | 0 | 0 | -4 | -4 | -4 | 2 | |
Cash & Cash Eqvt | 62 | 83 | 84 | 77 | 77 | 19 | 15 | 11 | 8 | 10 |
Mon, 16 May 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Loss / Misplacement of Share Certificate and Receipt of Application for issuance of Duplicate Share Certificate |
Mon, 09 May 2022
Update On Sale / Transfer Of Human Pharma Division (Undertaking) Of The Company With further reference to our Communication No.TTKH:SEC:GJ:037:22 dated 21st March 2022 on the above subject we wish to inform you that pursuant to the definitive agreements entered into on 21st March 2022 and the approval of the Shareholders by means of a Special Resolution passed through Postal Ballot process the Human Pharma Division (Undertaking) of the Company has been transferred to M/s BSV Pharma Private Limited effective from this date (i.e.) 9th May 2022. |
Tue, 03 May 2022
Minutes Of The Proceedings Held On 25Th April 2022 For Declaration Of Results Of The Postal Ballot Process Certified true copy of the Minutes of the proceedings held on Monday the 25th April 2022 for declaration of results of the Postal Ballot by way of remote e-Voting process for the Special Resolution deemed to have been passed by the Shareholders of the Company on Saturday the 23rd April 2022 being the last date of e-Voting. |
Fri, 20 May 2022 |
|
|
|
|
|